Skip to content

Abbott on ritonavir(Norvir™)

Which are the most useful questions to measure adherence?

Poor response to Hep C combination treatment in co-infected

$19 billion triple therapy bill for South Africa, even with price cuts

Decline in US AIDS deaths slowing

ABT-378/r/efavirenz warning: dose adjustment for highly PI-experienced

Response to HAART in non-Europeans: Conflicting data from UK centres

Latest US antiretroviral guidelines

3rd European Conference on Social and Behavioural Research on AIDS